Home Tags NYSE:CHK

Tag: NYSE:CHK

Recent Articles

Grabbing Eyeball Of Value Investors: Akcea Therapeutics, Inc. (AKCA), Freeport-McMoRan Inc. (FCX)

Here's what's interesting to note about Akcea Therapeutics, Inc. (NASDAQ:AKCA) right now: Its price-to-sales ratio of 32.04, is expensive relative to the Biotechnology universe...

Should You Buy At This Valuation? – Aduro BioTech, Inc. (ADRO), JD.com, Inc. (JD)

Investors making a wish list of stocks to watch should take a look at Aduro BioTech, Inc. (NASDAQ:ADRO). The stock is offering a price-to-sales...

Should Value Investors Consider BeiGene, Ltd. (BGNE) And General Motors Company (GM)?

BeiGene, Ltd. (NASDAQ:BGNE)'s price-to-sales ratio of 23.26 is creating a long-term opportunity in the value in its stock. The broad Biotechnology industry has an...